Mrs. Fatemeh Akbarzadeh | Health and Engineering | Best Researcher Award
Medical Physicist at Guilan University of Medical Sciences, Iran.
Fatemeh Akbarzadeh is a distinguished medical physicist from Rasht, Iran, holding an M.Sc. in Medical Physics from Kermanshah University of Medical Sciences, where she achieved a GPA of 3.953/4. Her research interests encompass cancer treatment, targeted therapy, drug delivery, and nanotechnology applications in oncology. Akbarzadeh has authored several publications in reputable journals, focusing on advanced therapeutic techniques, including the use of bismuth oxide nanoparticles for photodynamic therapy. She is also a patent holder for synthesizing targeted drug delivery systems, highlighting her innovative contributions to the field. With extensive experience as a Medical Physicist in various hospitals, she bridges theoretical research and clinical practice effectively. Despite her accomplishments, she could benefit from increased collaboration and broader publication reach. Overall, Fatemeh Akbarzadeh’s dedication to advancing cancer treatment and her strong academic background position her as a valuable asset in medical physics research.
Profile
Education
Fatemeh Akbarzadeh holds a Master of Science in Medical Physics from Kermanshah University of Medical Sciences, where she excelled with a remarkable GPA of 3.953 out of 4. Her graduate studies, completed in 2018, focused on integrating physics principles with medical applications, particularly in cancer treatment and radiotherapy. Prior to her master’s degree, she earned her Bachelor of Science in Radiotherapy Technology from Tehran University of Medical Sciences in 2014, achieving a GPA of 3.670 out of 4. This foundational education equipped her with essential skills in radiotherapy techniques and patient care, laying the groundwork for her research in targeted therapy and drug delivery systems. Fatemeh’s academic journey reflects her commitment to advancing medical technology and improving patient outcomes through innovative approaches in cancer diagnosis and treatment, positioning her as a knowledgeable professional in the field of medical physics.
Professional Experience
Fatemeh Akbarzadeh has extensive professional experience in the field of medical physics, specifically in radiation therapy. She is currently a Medical Physicist at Razi Hospital in Rasht, Guilan, Iran, where she applies her expertise in dosimetry and treatment planning to enhance patient care in oncology. Prior to this role, she worked at Velayat Hospital in Qazvin for three years, focusing on the implementation of radiation protection protocols and quality assurance measures in therapeutic procedures. Her earlier experience also includes serving as a Laboratory Expert in the Toxicology and Pharmacology Department at Kermanshah University of Medical Sciences, where she honed her skills in toxicology assessments and experimental research. This diverse background equips her with a comprehensive understanding of both the theoretical and practical aspects of medical physics, enabling her to contribute significantly to cancer treatment methodologies and enhance the effectiveness of radiotherapy.
Research Interest
Fatemeh Akbarzadeh’s research interests lie at the intersection of medical physics and oncology, focusing primarily on innovative strategies for cancer treatment. She explores targeted therapy, drug delivery, and photodynamic therapy, leveraging advancements in nanotechnology to enhance therapeutic efficacy. Her work emphasizes the development of nanoparticles, specifically bismuth oxide nanoparticles, for targeted drug delivery systems, aiming to improve the precision and effectiveness of cancer therapies while minimizing side effects. Additionally, her research encompasses radiation therapy, radiobiology, imaging, and dosimetry, contributing to a comprehensive understanding of how these modalities can be optimized for better patient outcomes. Fatemeh is particularly interested in the interplay between novel therapeutic agents and established treatment methods, seeking to create synergistic approaches that harness the strengths of both to combat cancer more effectively. Her commitment to advancing cancer diagnosis and treatment through rigorous scientific inquiry positions her as a significant contributor to the field of medical physics.
Research Skills
Fatemeh Akbarzadeh possesses a diverse and robust skill set that underpins her research in medical physics and cancer treatment. Her expertise includes cell culture and toxicology assessment, enabling her to conduct in vitro studies effectively. She is proficient in various assays, such as the MTT assay, Caspase-3 assay, and mitochondrial membrane potential assay, allowing her to evaluate cytotoxicity and therapeutic efficacy. Fatemeh’s skills extend to nanoparticle synthesis and drug conjugation, crucial for her work on targeted therapies and photodynamic treatment strategies. Additionally, she is adept at utilizing advanced software tools, including ImageJ, Prism, and SPSS, for data analysis and interpretation. Her experience with treatment planning systems (Monaco, PCRT-3D) and dosimetry further enhances her capability to contribute to radiotherapy advancements. Overall, Fatemeh’s comprehensive skill set not only supports her research endeavors but also positions her as a valuable contributor to the field of oncology and medical physics.
Award and Recognition
Fatemeh Akbarzadeh has garnered significant recognition for her innovative contributions to the field of medical physics, particularly in cancer treatment. With multiple publications in reputable journals, her research focuses on targeted therapy and nanotechnology, showcasing her commitment to advancing oncological therapies. Notably, she holds a patent for the synthesis of bismuth oxide nanoparticles, enhancing photodynamic therapy efficacy. Her academic excellence is reflected in her impressive GPA during her Master’s studies, affirming her strong foundation in the field. Additionally, she has actively participated in various international conferences, presenting her findings and fostering collaborations within the scientific community. Akbarzadeh’s role as a Medical Physicist in prominent hospitals further underscores her practical expertise and dedication to applying research findings in clinical settings. Her continuous pursuit of knowledge and innovation positions her as a leading figure in medical physics, making her a deserving candidate for awards and recognitions in her field.
Conclusion
Fatemeh Akbarzadeh is a commendable candidate for the Best Researcher Award, given her strong educational background, significant contributions to cancer treatment research, and practical experience as a Medical Physicist. Her innovative approaches in utilizing nanotechnology for drug delivery and photodynamic therapy position her as a promising researcher in her field. By addressing areas for improvement, particularly in collaboration and publication strategies, she can further enhance her research impact and recognition. Her dedication to advancing cancer treatment through rigorous scientific inquiry makes her a valuable asset to the medical physics community.
Publication Top Notes
- In vitro outlook of gold nanoparticles in photo-thermal therapy: a literature review
- Authors: H. Norouzi, K. Khoshgard, F. Akbarzadeh
- Year: 2018
- Journal: Lasers in Medical Science
- Volume/Issue/Page: 33, 917-926
- Citations: 126
- Investigating the cytotoxicity of folate-conjugated bismuth oxide nanoparticles on KB and A549 cell lines
- Authors: F. Akbarzadeh, K. Khoshgard, L. Hosseinzadeh, E. Arkan, D. Rezazadeh
- Year: 2018
- Journal: Advanced Pharmaceutical Bulletin
- Volume/Issue/Page: 8(4), 627
- Citations: 25
- Evaluating the photodynamic therapy efficacy using 5-aminolevulinic acid and folic acid-conjugated bismuth oxide nanoparticles on human nasopharyngeal carcinoma cell line
- Authors: F. Akbarzadeh, K. Khoshgard, E. Arkan, L. Hosseinzadeh, …
- Year: 2018
- Journal: Artificial Cells, Nanomedicine, and Biotechnology
- Volume/Issue/Page: 46(sup3), S514-S523
- Citations: 19
- Ratiometric bioassay and visualization of dopamine β-hydroxylase in brain cells utilizing a nanohybrid fluorescence probe
- Authors: N. Amin, A. Afkhami, L. Hosseinzadeh, F. Akbarzadeh, T. Madrakian, …
- Year: 2020
- Journal: Analytica Chimica Acta
- Volume/Issue/Page: 1105, 187-196
- Citations: 10
- Enhancement of the effect of novel targeted 5-aminolevulinic acid conjugated bismuth oxide nanoparticles-based photodynamic therapy by simultaneous radiotherapy on KB cells
- Authors: F. Akbarzadeh, K. Khoshgard
- Year: 2024
- Journal: Photodiagnosis and Photodynamic Therapy
- Volume/Issue/Page: 46, 104025
- Citations: 2
- Cytotoxicity of 5-ALA-conjugated bismuth oxide nanoparticles on KB cell line
- Authors: F. Akbarzadeh, K. Khoshgard, L. Hosseinzadeh, E. Arkan
- Year: 2018
- Journal: Iranian Journal of Medical Physics
- Volume/Issue/Page: 15 (Special Issue-12th Iranian Congress …)
- Investigating the cytotoxicity of folate and 5-aminolevulinic acid-conjugated bismuth oxide nanoparticles on KB and A549 cell lines
- Authors: F. Akbarzadeh, K. Khoshgard, L. Hosseinzadeh, E. Arkan, D. Rezazadeh
- Year: 2018